Achievements
Prof. Eliane Gluckman received the 2022 Lifetime Achievement Award of the Pediatric Transplantation and Cellular Therapy Consortium
During the tandem meeting of American society for transplantation and cellular therapy (ASTCT) and the Center for international blood and marrow transplant research (CIBMTR), which was held in Salt Lake City (USA) on 23-26 April 2022, Professor Eliane Gluckman has been honored to receive the prestigious “Lifetime Achievement Award of Pediatric Transplantation and Cellular Therapy Consortium”.
This very competitive prize rewards researchers who have made major contributions in the field of hematopoietic stem cell transplantation in children. This award crowns an entire career dedicated to cell therapy research that has resulted in the life-saving treatment of children with leukemia or life-threatening hereditary diseases. This distinction honors individuals whose work exemplifies the mission of the Pediatric Transplantation and Cellular Therapy Consortium “To support research and education to improve the availability, safety, and effectiveness of hematopoietic cell transplantation and other cell therapies for children and teenagers ».
Signature of the agreement between the Scientific Center of Monaco and the “Bambino Gesù” Hospital (Rome, Italy)
As part of scientific studies on sickle cell disease, collaborations have been established between Monacord and the pediatric hospital “Bambino Gesù”, Rome.
On September 26th 2019, in Rome, an agreement was signed between the Scientific Center of Monaco(CSM) and the “Bambino Gesù” Pediatric Hospital (OPGB) by Prof. Patrick Rampal, President of the CSM, and Mrs. Mariella Enoc, President of OPBG, in order to formalize and intensify a scientific collaboration on research projects by developing innovative protocols for cell and gene therapy in hemoglobinopathies.
Cord Blood Connect International conference”, Miami, USA, September 14-16, 2018
Celebration of the 30th anniversary of the first umbilical cord blood transplantation performed in Paris by Prof. Gluckman together with Prof Hal Broxmeyer, in 1988.
More than 50 members of the cord blood community from 14 different countries attended the meeting. The day included topics such as the global outlook for cord blood transplants, ethical dilemmas related to cord blood banks, common accreditation citations from FACT-NetCord and an overview of the WMDA cord blood banking survey. During the celebration of the 30th anniversary of this event, Prof. Gluckman received the first Cord Blood Association’s (CBA) Lifetime Achievement Award.
Mission Tanzania, August 2018
The objective of this project entitled “Development of cord blood and bone marrow transplant centers in Africa” is the creation of a center of excellence for hematopoietic stem cell transplantations and gene therapy for sickle cell disease within the MUHAS Academic Medical Center in Dar el Salam in Tanzania.
This project was the subject of an application for approval from the APHP in Paris and the universities of Paris-Diderot and Paris-Descartes for the establishment and training of the center. An exchange and collaboration program has been set up. This project was funded to promote exchanges between APHP and Mumbilhi Hospital.
Establishment of a BMT –CHARTA consortium: Blood and Marrow transplant –Consortium for Health, Advocacy, Research and training in Africa
This consortium will expand the bone marrow transplant program to other countries including Tanzania, Ghana, Nigeria, Democratic Republic of Congo and Senegal. These centers have already been contacted and agreed to join this consortium
Japan Mission, November 7-9, 2018
Gluckman participated in “Kyoto cord blood transplantation symposium” and “Tokyo cord blood symposium”
In Kyoto
Eurocord – Monacord established relationships with Center CIRA (Center for IPS Cell Research and Application) directed by the Nobel Prize winner Prof. Yamanaka; in order to collaborate on studies for the application of IPS for cell and gene therapy.
Prof Gluckman met also Prof. Kawamoto, specialist in anti-infectious and anti-tumor immunotherapy, from the Institute for Frontiers Medical Sciences and prof. Matsuda from the Center for Genomic medicine, in order to set up, with the latter, a comparison study of HLA polymorphisms between European, Japanese and African populations.
In Tokyo
In Tokyo prof. Gluckman met Pr S. Takahashi from Institute of Medical Science, the University of Tokyo (IMSUT), cell molecular therapy laboratory , in order to have an exchange session with researchers.
